ImpediMed Names Erik Anderson as New Chief Executive Officer Amid Business Expansion ImpediMed has appointed Erik Anderson as CEO following his successful tenure at Hologic. His focus will be on growth and expanding product adoption.

ImpediMed Names Erik Anderson as New Chief Executive Officer Amid Business Expansion #United_States #Carlsbad #ImpediMed #BCRL #Erik_Anderson

Disparities in Breast Cancer–related Lymphedema: A Systematic Review of Inequities and Barriers in Care Breast cancer–related lymphedema (BCRL) is a chronic condition secondary to multimodal cancer treatment. This systematic review summarized the evidence for disparities and barriers surrounding BCRL ca...

Improving QOL for pts with #breastcancer related #lymphedema requires timely diagnosis, education, + access to care. Vulnerable populations face the greatest barriers highlighting the need for surveillance + support.
pmc.ncbi.nlm.nih.gov/articles/PMC...
#BCRL @yaleschoolofmed.bsky.social

ImpediMed Honored with Frost & Sullivan's 2025 Technology Innovation Leadership Award ImpediMed has earned the prestigious Frost & Sullivan 2025 Technology Innovation Leadership Award, showcasing its advanced SOZO® Digital Health Platform for monitoring health.

ImpediMed Honored with Frost & Sullivan's 2025 Technology Innovation Leadership Award #United_States #Carlsbad #ImpediMed #SOZO® #BCRL

🌟 Hello, Bluesky! 🌟 We're the Baby and Child Rebel Lab at UNLV, where we explore how infants, children, and adults learn about the social world. 💡 🧠✨ Follow us for research updates, community events, and more! #UNLVResearch #BlueskyScience #ChildDevelopment #unlvchildlab #bcrl #unlv